Expanding the yeast prion world Active prion conversion of non-glutamine/asparagine-rich Mod5 for cell survival

被引:11
|
作者
Suzuki, Genjiro [1 ]
Tanaka, Motomasa [1 ]
机构
[1] RIKEN Brain Sci Inst, Lab Prot Conformat Dis, Wako, Saitama, Japan
关键词
prion; amyloid; Mod5; tRNA isopentenyltransferase; antifungal drug; cellular adaptation; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; PSI+ PRION; Q/N-RICH; PROTEIN; DISEASES; INHERITANCE; PROPAGATE; MECHANISM; VITRO;
D O I
10.4161/pri.22685
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian and fungal prion proteins form self-perpetuating beta-sheet-rich fibrillar aggregates called amyloid. Prion inheritance is based on propagation of the regularly oriented amyloid structures of the prion proteins. All yeast prion proteins identified thus far contain aggregation-prone glutamine/asparagine (Gln/Asn)-rich domains, although the mammalian prion protein and fungal prion protein HET-s do not contain such sequences. In order to fill this gap, we searched for novel yeast prion proteins lacking Gln/Asn-rich domains via a genome-wide screen based on cross-seeding between two heterologous proteins and identified Mod5, a yeast tRNA isopentenyltransferase, as a novel non-Gln/Asn-rich yeast prion protein. Mod5 formed self-propagating amyloid fibers in vitro and the introduction of Mod5 amyloids into non-prion yeast induced dominantly and cytoplasmically heritable prion state [MOD+], which harbors aggregates of endogenous Mod5. [MOD+] yeast showed an increased level of membrane lipid ergosterol and acquired resistance to antifungal agents. Importantly, enhanced de novo formation of [MOD+] was observed when non-prion yeast was grown under selective pressures from antifungal drugs. Our findings expand the family of yeast prions to non-Gln/Asn-rich proteins and reveal the acquisition of a fitness advantage for cell survival through active prion conversion.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 1 条